Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 39,795 | 33,908 | 30,761 | 29,208 | 93,761 |
| Cost of Goods | 4,480 | 3,765 | 2,884 | 2,982 | 1,590 |
| Gross Profit | 35,315 | 30,143 | 27,877 | 26,226 | 92,171 |
| Operating Expenses | 60,046 | 65,882 | 69,828 | 92,540 | 63,125 |
| Operating Income | -24,251 | -34,974 | -41,067 | -65,332 | 29,636 |
| Other Income | 4,525 | 4,652 | 5,071 | 6,092 | 6,519 |
| Pre-tax Income | -19,726 | -30,322 | -35,996 | -59,240 | 36,155 |
| Income Tax | N/A | N/A | N/A | 6,474 | -882 |
| Net Income Continuous | -19,726 | -30,322 | -35,996 | -65,714 | 37,037 |
| Net Income | $-19,726 | $-30,322 | $-35,996 | $-65,714 | $37,037 |
| EPS Basic Total Ops | -0.19 | -0.29 | -0.35 | -0.63 | 0.38 |
| EPS Basic Continuous Ops | -0.19 | -0.29 | -0.35 | -0.64 | 0.38 |
| EPS Diluted Total Ops | -0.19 | -0.29 | -0.35 | -0.63 | 0.38 |
| EPS Diluted Continuous Ops | -0.19 | -0.29 | -0.35 | -0.64 | 0.38 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.29 | -0.35 | -0.69 | 0.38 |
| EBITDA(a) | $-23,317 | $-34,010 | $-40,173 | $-64,573 | $30,382 |